{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:04:23Z","timestamp":1769753063434,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860838"],"award-info":[{"award-number":["81860838"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ctim.2022.102831","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T11:46:54Z","timestamp":1649332014000},"page":"102831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Comparative efficacy of seven Chinese patent medicines for early diabetic kidney disease: A Bayesian network meta-analysis"],"prefix":"10.1016","volume":"67","author":[{"given":"Jie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LiFeng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ctim.2022.102831_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines","volume":"22","author":"Selby","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ctim.2022.102831_bib2","unstructured":"Federation ID. International Diabetes Federation Diabetes Atlas. Brussels, Belgium; 2019. 9th ed.; Updated: 2020 Feb 12. \u3008https:\/\/www.idf.org\/\u3009."},{"issue":"6","key":"10.1016\/j.ctim.2022.102831_bib3","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes, 1988\u20132014","volume":"316","author":"Afkarian","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ctim.2022.102831_bib4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.drudis.2020.01.008","article-title":"Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities","volume":"25","author":"Raval","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ctim.2022.102831_bib5","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.12659\/MSM.913512","article-title":"Long-term intensive lifestyle intervention promotes improvement of stage III diabetic nephropathy","volume":"25","author":"Dong","year":"2019","journal-title":"Med Sci Monit"},{"issue":"8","key":"10.1016\/j.ctim.2022.102831_bib6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S2213-8587(16)30045-6","article-title":"Unmet need in diabetic nephropathy: failed drugs or trials?","volume":"4","author":"de Zeeuw","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.ctim.2022.102831_bib7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00125-017-4301-8","article-title":"SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA adverse event reporting system","volume":"60","author":"Fadini","year":"2017","journal-title":"Diabetologia"},{"issue":"43","key":"10.1016\/j.ctim.2022.102831_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017495","article-title":"Effectiveness comparisons of traditional Chinese medicine on treating diabetic nephropathy proteinuria: a systematic review and meta-analysis","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.ctim.2022.102831_bib9","unstructured":"Administration NMP. What in Chinese patent medicine; 2017. \u3008https:\/\/www.nmpa.gov.cn\/xxgk\/kpzhsh\/kpzhshyp\/20171024101101251.html\u3009. [Accessed 29th July 2021]."},{"issue":"2","key":"10.1016\/j.ctim.2022.102831_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/j.jrn.2019.03.083","article-title":"Clinical efficacy and safety of jinshuibao combined with ACEI\/ARB in the treatment of diabetic kidney disease: a meta-analysis of randomized controlled trials","volume":"30","author":"Li","year":"2020","journal-title":"J Ren Nutr"},{"issue":"6","key":"10.1016\/j.ctim.2022.102831_bib11","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.21037\/apm-20-1799","article-title":"Efficacy and safety of bailing capsules in the treatment of type 2 diabetic nephropathy: a meta-analysis","volume":"9","author":"Sheng","year":"2020","journal-title":"Ann Palliat Med"},{"issue":"2","key":"10.1016\/j.ctim.2022.102831_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.7326\/0003-4819-159-2-201307160-00008","article-title":"Conceptual and technical challenges in network meta-analysis","volume":"159","author":"Cipriani","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ctim.2022.102831_bib13","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2017047","article-title":"Network meta-analysis: application and practice using Stata","volume":"39","author":"Shim","year":"2017","journal-title":"Epidemiol Health"},{"issue":"2","key":"10.1016\/j.ctim.2022.102831_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ctim.2022.102831_bib15","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ctim.2022.102831_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ki.1987.50","article-title":"Microalbuminuria as a predictor of clinical diabetic nephropathy","volume":"31","author":"Mogensen","year":"1987","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.ctim.2022.102831_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med"},{"key":"10.1016\/j.ctim.2022.102831_bib18","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ctim.2022.102831_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.ctim.2022.102831_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth Methods"},{"issue":"1","key":"10.1016\/j.ctim.2022.102831_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ije\/dys222","article-title":"Evaluation of inconsistency in networks of interventions","volume":"42","author":"Veroniki","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ctim.2022.102831_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"J Clin Epidemiol"},{"issue":"20","key":"10.1016\/j.ctim.2022.102831_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025759","article-title":"Bailing Capsule combined with \u03b1-ketoacid tablets for stage 3 chronic kidney disease: protocol of a double-blinded, randomized, controlled trial","volume":"100","author":"Hu","year":"2021","journal-title":"Medicine"},{"issue":"19","key":"10.1016\/j.ctim.2022.102831_bib24","first-page":"5","article-title":"Progress on pharmaceutical effects of natural cordyceps sinensis and fermentative cordycepic. Fungal powder in recent five years","volume":"17","author":"Peng","year":"2020","journal-title":"Drug Eval"},{"issue":"05","key":"10.1016\/j.ctim.2022.102831_bib25","first-page":"1712","article-title":"Clinical efficacy of HuangKui capsules combined with ACEI or ARB in patients with diabetic nephropathy: a meta-analysis","volume":"30","author":"Liu","year":"2015","journal-title":"China J Tradit Chin Med Pharm"},{"key":"10.1016\/j.ctim.2022.102831_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.phymed.2018.12.021","article-title":"Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4\/NF-\u03baB signaling","volume":"57","author":"Han","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ctim.2022.102831_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113548","article-title":"Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho\/TGF-\u03b21\/p38MAPK signaling pathway","volume":"281","author":"Gu","year":"2021","journal-title":"J Ethnopharm"},{"issue":"12","key":"10.1016\/j.ctim.2022.102831_bib28","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s11655-013-1654-9","article-title":"Inhibition of the tubular epithelial-to-mesenchymal transition in vivo and in vitro by the uremic clearance granule","volume":"19","author":"Lu","year":"2013","journal-title":"Chin J Integr Med"},{"issue":"3","key":"10.1016\/j.ctim.2022.102831_bib29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s11655-018-2998-y","article-title":"Effects of niaoduqing particles on delaying progression of renal dysfunction: a post-trial, open-label, follow-up study","volume":"25","author":"Zheng","year":"2019","journal-title":"Chin J Integr Med"},{"issue":"21","key":"10.1016\/j.ctim.2022.102831_bib30","first-page":"4159","article-title":"Advance in studies on anti-inflammatory and immunoregulatory monomers of Tripterygium wilfordii","volume":"39","author":"Li","year":"2014","journal-title":"China J Chin Mater Med"},{"key":"10.1016\/j.ctim.2022.102831_bib31","doi-asserted-by":"crossref","first-page":"9148523","DOI":"10.1155\/2017\/9148523","article-title":"Tripterygium wilfordii glycosides upregulate the new anti-inflammatory cytokine IL-37 through ERK1\/2 and p38 MAPK signal pathways","volume":"2017","author":"Wang","year":"2017","journal-title":"Evid Based Complement Altern Med"},{"issue":"1","key":"10.1016\/j.ctim.2022.102831_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11418-012-0654-y","article-title":"Attenuating effect of Fufang Xueshuantong capsule on kidney function in diabetic nephropathy model","volume":"67","author":"Zhang","year":"2013","journal-title":"J Nat Med"},{"issue":"1","key":"10.1016\/j.ctim.2022.102831_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11418-020-01452-3","article-title":"Shenyan Kangfu tablet alleviates diabetic kidney disease through attenuating inflammation and modulating the gut microbiota","volume":"75","author":"Chen","year":"2021","journal-title":"J Nat Med"},{"key":"10.1016\/j.ctim.2022.102831_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113817","article-title":"Network pharmacology combined with metabolomics to study the mechanism of Shenyan Kangfu tablets in the treatment of diabetic nephropathy","volume":"270","author":"Wang","year":"2021","journal-title":"J Ethnopharm"},{"key":"10.1016\/j.ctim.2022.102831_bib35","doi-asserted-by":"crossref","first-page":"6806943","DOI":"10.1155\/2018\/6806943","article-title":"Clinical efficacy of Jinshuibao capsules combined with angiotensin receptor blockers in patients with early diabetic nephropathy: a meta-analysis of randomized controlled trials","volume":"2018","author":"Lu","year":"2018","journal-title":"Evid Based Complement Altern Med"},{"issue":"2","key":"10.1016\/j.ctim.2022.102831_bib36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0254-6272(13)60137-5","article-title":"Retrospective study on Professor Zhongying Zhou's experience in Traditional Chinese Medicine treatment on diabetic nephropathy","volume":"33","author":"Su","year":"2013","journal-title":"J Tradit Chin Med"},{"issue":"11","key":"10.1016\/j.ctim.2022.102831_bib37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11655-016-2746-0","article-title":"Relationship between two blood stasis syndromes and inflammatory factors in patients with acute coronary syndrome","volume":"23","author":"Ma","year":"2017","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.ctim.2022.102831_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620931931","article-title":"Research progress of oxidative stress and microRNAs in the prevention of catheter-related thrombus under resistance exercise","volume":"26","author":"Wen","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"10.1016\/j.ctim.2022.102831_bib39","first-page":"349","article-title":"Xueshuantong for injection ameliorates diabetic nephropathy in a rat model of streptozotocin-induced diabetes","volume":"61","author":"Wang","year":"2018","journal-title":"Chin J Physiol"},{"issue":"20","key":"10.1016\/j.ctim.2022.102831_bib40","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.4103\/0366-6999.216407","article-title":"Efficacy and safety of niaoduqing particles for delaying moderate-to-severe renal dysfunction: a randomized, double-blind, placebo-controlled, multicenter clinical study","volume":"130","author":"Zheng","year":"2017","journal-title":"Chin Med J"},{"key":"10.1016\/j.ctim.2022.102831_bib41","article-title":"Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases","author":"Li","year":"2020","journal-title":"Phytother Res"},{"issue":"11","key":"10.1016\/j.ctim.2022.102831_bib42","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20202391","article-title":"Efficacy of tripterygium glycosides combined with ARB on diabetic nephropathy: a meta-analysis","volume":"40","author":"Wu","year":"2020","journal-title":"Biosci Rep"},{"issue":"11","key":"10.1016\/j.ctim.2022.102831_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113798","article-title":"Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy","volume":"21","author":"Rayego-Mateos","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.ctim.2022.102831_bib44","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/1099-1573(200012)14:8<650::AID-PTR675>3.0.CO;2-0","article-title":"Inhibitory effects of water extracts from fruiting bodies of cultured Cordyceps sinensis on raised serum lipid peroxide levels and aortic cholesterol deposition in atherosclerotic mice","volume":"14","author":"Yamaguchi","year":"2000","journal-title":"Phytother Res"},{"issue":"10","key":"10.1016\/j.ctim.2022.102831_bib45","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3760\/cma.j.issn.0366-6999.20130483","article-title":"Effects of Bailing capsules for renal transplant recipients: a retrospective clinical study","volume":"126","author":"Wang","year":"2013","journal-title":"Chin Med J"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229922000334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229922000334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:17:19Z","timestamp":1760807839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229922000334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":45,"alternative-id":["S0965229922000334"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2022.102831","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy of seven Chinese patent medicines for early diabetic kidney disease: A Bayesian network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2022.102831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102831"}}